National Health Investors, Inc. Forecast, price target & analysts
National Health Investors, Inc. Target price 2025 - Analyst rating & recommendation
National Health Investors, Inc. Classifications & Recommendation:
National Health Investors, Inc. Price Target
| Target Price | $77.33 |
| Price | $71.25 |
| Potential |
8.54%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target National Health Investors, Inc. 2026 .
The average National Health Investors, Inc. target price is $77.33.
This is
8.54%
register free of charge
$90.00
26.32%
register free of charge
$66.00
7.37%
register free of charge
|
|
| A rating was issued by 7 analysts: 3 Analysts recommend National Health Investors, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the National Health Investors, Inc. stock has an average upside potential 2026 of
8.54%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 338.07 | 272.08 |
| 4.87% | 19.52% | |
| EBITDA Margin | 78.05% | 103.20% |
| 0.05% | 32.21% | |
| Net Margin | 42.30% | 54.74% |
| 4.65% | 29.40% |
5 Analysts have issued a sales forecast National Health Investors, Inc. 2025 . The average National Health Investors, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an National Health Investors, Inc. EBITDA forecast 2025. The average National Health Investors, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast National Health Investors, Inc. 2025 . The average National Health Investors, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.13 | 3.26 |
| 0.00% | 4.15% | |
| P/E | 21.86 | |
| EV/Sales | 16.16 |
1 Analysts have issued a National Health Investors, Inc. forecast for earnings per share. The average National Health Investors, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the National Health Investors, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
National Health Investors, Inc....
Current National Health Investors, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities | Locked ➜ Locked | Locked | Dec 23 2024 |
| B of A Securities | Locked ➜ Locked | Locked | Sep 24 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Aug 30 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities: Locked ➜ Locked
|
Dec 23 2024 |
|
Locked
B of A Securities: Locked ➜ Locked
|
Sep 24 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Aug 30 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
